Tuesday, January 27, 2009

ADHD Drugs: Hallucinations Not Uncommon

FDA Examines Incidence of Psychotic Symptoms in Children Taking ADHD Medications
Jan. 26, 2009 -- Treatment-related hallucinations and other psychotic symptoms in children with attention deficit hyperactivity disorder (ADHD) may be more common than previously thought, FDA officials report in the latest issue of the journal Pediatrics
To View Full Article: http://www.webmd.com/add-adhd/news/20090126/adhd-drugs-hallucinations-not-uncommon

Wednesday, January 14, 2009

Study Raises Questions About Diagnosis & ADHD Treatment

A new UCLA study shows that only about half of children diagnosed with attention-deficit hyperactivity disorder, or ADHD, exhibit the cognitive defects commonly associated with the condition.The study also found that in populations where medication is rarely prescribed to treat ADHD, the prevalence and symptoms of the disorder are roughly equivalent to populations in which medication is widely used.The results of the first large, longitudinal study of adolescents and ADHD, conducted among the population of northern Finland, appeared in several papers in a special section of the Journal of the American Academy of Child and Adolescent Psychiatry published in December and are currently online. To view full article: http://www.medicalnewstoday.com/articles/94801.php

STRATTERA WARNING

The ADHD drug Strattera CAUSES psychosis, hallucinations, mania and agitation - 12/01/2008-The manufacturer, Eli Lilly, has now changed the label for Strattera in Europe to include warnings that Strattera CAUSES “hallucinations, delusional thinking, mania or agitation in children and adolescents without a prior history of psychotic illness or mania … at usual doses”। Stockholm, Sweden 12/01/2008 09:38 PM GMT (TransWorldNews) - To View Full Article: http://www.transworldnews.com/NewsStory.aspx?id=69298&cat=10

Strattera Safety Questioned

STRATTERA-Children's suicide attempts raise concerns about ADHD medication - July 3, 2008-New questions are being raised about the safety of a drug used to treat attention-deficit hyperactivity disorder amid reports that more than 40 Canadian children have attempted suicide after taking it। To View Full Article: http://www.theglobeandmail.com/servlet/story/RTGAM.20080703.wadhd03/BNStory/specialScienceandHealth/home